These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

83 related articles for article (PubMed ID: 18068627)

  • 1. New breast cancer genes-discovery at the intersection of complex data sets.
    Nevins JR
    Cancer Cell; 2007 Dec; 12(6):497-9. PubMed ID: 18068627
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cell-surface and mitotic-spindle RHAMM: moonlighting or dual oncogenic functions?
    Maxwell CA; McCarthy J; Turley E
    J Cell Sci; 2008 Apr; 121(Pt 7):925-32. PubMed ID: 18354082
    [TBL] [Abstract][Full Text] [Related]  

  • 3. New genes potentially involved in breast cancer metastasis.
    Schwirzke M; Schiemann S; Gnirke AU; Weidle UH
    Anticancer Res; 1999; 19(3A):1801-14. PubMed ID: 10470119
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Use of expression data and the CGEMS genome-wide breast cancer association study to identify genes that may modify risk in BRCA1/2 mutation carriers.
    Walker LC; Waddell N; Ten Haaf A; ; Grimmond S; Spurdle AB
    Breast Cancer Res Treat; 2008 Nov; 112(2):229-36. PubMed ID: 18095154
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Altered expression of proliferation-inducing and proliferation-inhibiting genes might contribute to acquired doxorubicin resistance in breast cancer cells.
    Saleh EM; El-Awady RA; Abdel Alim MA; Abdel Wahab AH
    Cell Biochem Biophys; 2009; 55(2):95-105. PubMed ID: 19593673
    [TBL] [Abstract][Full Text] [Related]  

  • 6. DNA copy number alterations and expression of relevant genes in triple-negative breast cancer.
    Han W; Jung EM; Cho J; Lee JW; Hwang KT; Yang SJ; Kang JJ; Bae JY; Jeon YK; Park IA; Nicolau M; Jeffrey SS; Noh DY
    Genes Chromosomes Cancer; 2008 Jun; 47(6):490-9. PubMed ID: 18314908
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Dinucleotide repeat polymorphisms of RAD51, BRCA1, BRCA2 gene regions in breast cancer.
    Nowacka-Zawisza M; Brys M; Romanowicz-Makowska H; Kulig A; Krajewska WM
    Pathol Int; 2008 May; 58(5):275-81. PubMed ID: 18429825
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pointing (zinc) fingers at BRCA1 targets.
    MacLachlan TK; El-Deiry WS
    Nat Med; 2000 Dec; 6(12):1318-9. PubMed ID: 11100109
    [No Abstract]   [Full Text] [Related]  

  • 9. Wnt signalling in human breast cancer: expression of the putative Wnt inhibitor Dickkopf-3 (DKK3) is frequently suppressed by promoter hypermethylation in mammary tumours.
    Veeck J; Bektas N; Hartmann A; Kristiansen G; Heindrichs U; Knüchel R; Dahl E
    Breast Cancer Res; 2008; 10(5):R82. PubMed ID: 18826564
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Update on genetic predisposition to breast cancer.
    Ahmed M; Lalloo F; Evans DG
    Expert Rev Anticancer Ther; 2009 Aug; 9(8):1103-13. PubMed ID: 19671030
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hereditary cancer gene hunting. a phase of declining success?
    Eisinger F; Horsman D
    Med Hypotheses; 2007; 69(3):690-2. PubMed ID: 17363177
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Systematic analyses of the cancer genome: lessons learned from sequencing most of the annotated human protein-coding genes.
    Sjöblom T
    Curr Opin Oncol; 2008 Jan; 20(1):66-71. PubMed ID: 18043258
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Skewed X chromosome inactivation and breast and ovarian cancer status: evidence for X-linked modifiers of BRCA1.
    Lose F; Duffy DL; Kay GF; Kedda MA; Spurdle AB; ;
    J Natl Cancer Inst; 2008 Nov; 100(21):1519-29. PubMed ID: 18957670
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pharmacogenetics of breast cancer: toward the individualization of therapy.
    Chang JC; Hilsenbeck SG; Fuqua SA
    Cancer Invest; 2009 Aug; 27(7):699-703. PubMed ID: 19637041
    [No Abstract]   [Full Text] [Related]  

  • 15. Integrated gene expression profile predicts prognosis of breast cancer patients.
    Li LF; Xu XJ; Zhao Y; Liu ZB; Shen ZZ; Jin WR; Shao ZM
    Breast Cancer Res Treat; 2009 Jan; 113(2):231-7. PubMed ID: 18278552
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Molecular pathways in tumor progression: from discovery to functional understanding.
    Ali MA; Sjöblom T
    Mol Biosyst; 2009 Sep; 5(9):902-8. PubMed ID: 19668850
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Posttranscriptional regulation of the breast cancer susceptibility gene BRCA1 by the RNA binding protein HuR.
    Saunus JM; French JD; Edwards SL; Beveridge DJ; Hatchell EC; Wagner SA; Stein SR; Davidson A; Simpson KJ; Francis GD; Leedman PJ; Brown MA
    Cancer Res; 2008 Nov; 68(22):9469-78. PubMed ID: 19010922
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Structural and functional properties of genes involved in human cancer.
    Furney SJ; Higgins DG; Ouzounis CA; López-Bigas N
    BMC Genomics; 2006 Jan; 7():3. PubMed ID: 16405732
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mechanisms of Disease: prediction and prevention of breast cancer--cellular and molecular interactions.
    Howell A; Sims AH; Ong KR; Harvie MN; Evans DG; Clarke RB
    Nat Clin Pract Oncol; 2005 Dec; 2(12):635-46. PubMed ID: 16341119
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Re: Molecular basis for estrogen receptor alpha deficiency in BRCA1-linked breast cancer.
    Lusa L; Peissel B; Manoukian S; Marchesi E; Radice P; Pierotti MA; Gariboldi M
    J Natl Cancer Inst; 2008 May; 100(10):752-3; author reply 753-4. PubMed ID: 18477803
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.